BE872319A - Composition pharmaceutique - Google Patents

Composition pharmaceutique

Info

Publication number
BE872319A
BE872319A BE191971A BE191971A BE872319A BE 872319 A BE872319 A BE 872319A BE 191971 A BE191971 A BE 191971A BE 191971 A BE191971 A BE 191971A BE 872319 A BE872319 A BE 872319A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BE191971A
Other languages
English (en)
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of BE872319A publication Critical patent/BE872319A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE191971A 1977-11-30 1978-11-27 Composition pharmaceutique BE872319A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB49759/77A GB1571629A (en) 1977-11-30 1977-11-30 Pharmaceutical compositions containing beclomethasone dipropionate

Publications (1)

Publication Number Publication Date
BE872319A true BE872319A (fr) 1979-05-28

Family

ID=10453448

Family Applications (1)

Application Number Title Priority Date Filing Date
BE191971A BE872319A (fr) 1977-11-30 1978-11-27 Composition pharmaceutique

Country Status (7)

Country Link
US (1) US4199578A (fr)
JP (1) JPS5484022A (fr)
AU (1) AU525470B2 (fr)
BE (1) BE872319A (fr)
DE (1) DE2851489A1 (fr)
FR (1) FR2423218A1 (fr)
GB (1) GB1571629A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9365905B2 (en) 2005-02-10 2016-06-14 Dmv-Fonterra Excipients Technology Gmbh Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IT1212896B (it) * 1983-11-08 1989-11-30 Della Valle Francesco Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
DK0416950T3 (da) * 1989-09-08 1993-10-11 Glaxo Group Ltd Medikamenter
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US6380222B2 (en) * 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
SE9603725D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New teatment
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
EP0876814A1 (fr) * 1997-05-07 1998-11-11 "PHARLYSE", Société Anonyme Exipient pour inhalateur à poudre sèche, procédé de sa préparation et compositions pharmaceutiques la contenant
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
US6551578B2 (en) * 2001-02-15 2003-04-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
EP2708225B1 (fr) 2004-04-23 2018-12-26 CyDex Pharmaceuticals, Inc. Formulation DPI contenant de la cyclodextrine d'éther de sulfoalkyle
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB937303A (en) * 1959-01-02 1963-09-18 Benger Lab Ltd Improvements in and relating to the application of drugs in finely divided condition
GB1381872A (en) * 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1440064A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd Delta8-9- steroids of the pregnane series
US4039668A (en) * 1973-06-23 1977-08-02 Schering Aktiengesellschaft Corticoid-containing inhalants

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9365905B2 (en) 2005-02-10 2016-06-14 Dmv-Fonterra Excipients Technology Gmbh Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom

Also Published As

Publication number Publication date
FR2423218B1 (fr) 1984-05-25
AU4210078A (en) 1979-06-07
AU525470B2 (en) 1982-11-11
DE2851489A1 (de) 1979-05-31
JPS5484022A (en) 1979-07-04
US4199578A (en) 1980-04-22
GB1571629A (en) 1980-07-16
FR2423218A1 (fr) 1979-11-16

Similar Documents

Publication Publication Date Title
BE872319A (fr) Composition pharmaceutique
SE7810591L (sv) Farmaceutiska kompositioner
FI783917A (fi) Aminderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner
BE859288A (fr) Composition pharmaceutique a liberation etalee
FI800910A (fi) Farmaceutiskt anvaendbara 4-amino-3-kinolinkarboxylsyror och -estrar
BE854150A (fr) Composition pharmaceutique analgesique
SE7711395L (sv) Farmaceutisk komposition
RO78326A (fr) Composition herbicide
IT1109334B (it) Composizione insetticida
FI791456A (fi) Farmaceutiska foereningar
IT1095377B (it) Composizione farmaceutica
AR218662A1 (es) Composicion insecticida
FI790404A (fi) Farmaceutiska sammansaettningar
IT7867018A0 (it) Composizione antiulcera
RO85275A (fr) Composition milldincide
FI783796A (fi) Faergframkallande komposition
FI782442A (fi) Stelnad farmaceutisk foerening innehaollande cellvaeggsmaterial
SE7806441L (sv) Lekemedelskomposition
IT7849938A0 (it) Composizioni farmaceutiche
FI773882A (fi) Komposition
FR2326189A2 (fr) Composition pharmaceutique
DK461579A (da) Farmeceutisk komposition indeholdende en aryltrifluorethanol
IT1101681B (it) Composizione funcicida
FI781435A (fi) Fungicid komposition
NL7801464A (nl) Farmaceutische samenstellingen.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FISONS LTD

Effective date: 19851130